Previous close | 161.33 |
Open | 161.33 |
Bid | N/A x N/A |
Ask | N/A x N/A |
Day's range | 161.33 - 161.33 |
52-week range | 111.91 - 161.33 |
Volume | |
Avg. volume | 19 |
Market cap | 38.409B |
Beta (5Y monthly) | 0.26 |
PE ratio (TTM) | 36.92 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | 2.24 (1.39%) |
Ex-dividend date | 10 May 2024 |
1y target est | N/A |
LONDON, April 26, 2024--The European financial landscape saw a milestone event this week, as the EU Parliament passed the Amendment to Regulation (EU) No 575/2013, implementing the Basel III finalization within Europe.
NEW YORK, April 25, 2024--Wolters Kluwer, a global leader in information, software, and services for professionals, announces that it has won two Stevie® Awards at the 2024 American Business Awards®. Wolters Kluwer TeamMate+ ESG has been recognized as a Gold Stevie winner in the compliance solution category and Enablon ESG Excellence received a Silver Stevie Award in the emerging technology category.
NEW YORK, April 25, 2024--Wolter’s Kluwer’s MediRegs has been named a winner in the Healthcare category of the 2024 BIG Innovation Awards. The solution, offered by the company’s Legal & Regulatory division, recently launched an Analytical APIs service leveraging automated analytics. Healthcare revenue cycle, reimbursement, and audit professionals can now use MediRegs to bolster efficiency and cash collections during the audit and appeals process.